NCT02587988View on ClinicalTrials.gov

Trial to Evaluate the Efficacy and Safety of HCP1302

PHASE3CompletedINTERVENTIONAL
Enrollment

232

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

August 31, 2015

Conditions
Erectile DysfunctionHypertension
Interventions
DRUG

HCP1302

DRUG

HGP0904

DRUG

Placebo (for HCP1302)

DRUG

Placebo (for HGP0904)

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT02587988 - Trial to Evaluate the Efficacy and Safety of HCP1302 | Biotech Hunter | Biotech Hunter